{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:12:39Z","timestamp":1780510359146,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P021220"],"award-info":[{"award-number":["MR\/P021220"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Current guidelines advocate individualised HbA1c targets among frail individuals, but the evidence base remains limited. We therefore evaluated whether electronic frailty index (eFI) could improve model performance for mortality and hospital admission, and examined the association between HbA1c levels and clinical outcomes across frailty strata in large UK primary care population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients with type 2 diabetes mellitus aged \u226565\u00a0years within the UK based Clinical Practice Research Datalink (CPRD GOLD) and Hospital Episode Statistics from 2014\u201319. Step-wise multivariate Cox regression models were developed for all-cause mortality and hospital admission. Model performance before and after the addition of eFI using Akaike\u2019s information criteria (AIC) and Harrell\u2019s C statistics was analysed and the risk for both outcomes associated with eFI and HbA1c groups were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>N\u00a0=\u2009179\u2009723 individuals (mean age 74.8\u2009\u00b1\u20097.6\u00a0years; diabetes duration 7.3\u2009\u00b1\u20096.1\u00a0years) were included and followed over 1.7\u00a0years. Incorporating eFI may improve model performance for both mortality and admission outcomes, reducing AIC (\u0394AIC -1423.1 and \u0394AIC -308.4 for admission and mortality, respectively) and improving Harrell\u2019s C statistics (standard model vs. EFI; 0.616 vs. 0.631 and 0.776 vs. 0.778). All-cause mortality risk was lowest at HbA1c 48\u201357.9\u00a0mmol\/mol and increased at both lower and higher HbA1c levels across all frailty groups. The highest risk of hospital admission was consistently observed at HbA1c &amp;lt;48\u00a0mmol\/mol, particularly in individuals with severe frailty (HR 4.33; 95% CI: 3.64\u20135.15).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>eFI may enhance model performance for mortality and hospital admissions and may support clinical decision-making by identifying frail individuals for whom intensive glycaemic control is less appropriate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag149","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:30:26Z","timestamp":1778585426000},"source":"Crossref","is-referenced-by-count":0,"title":["The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetes"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-8262","authenticated-orcid":false,"given":"Thomas S J","family":"Crabtree","sequence":"first","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]},{"name":"Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trust , Derby ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Aldafas","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]},{"name":"Faculty of Public Health, College of Health Science, The Saudi Electronic University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-0644","authenticated-orcid":false,"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gordon","sequence":"additional","affiliation":[{"name":"Elevate Access Ltd , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Vinogradova","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]},{"name":"Elevate Access Ltd , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskandar","family":"Idris","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]},{"name":"Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trust , Derby ,","place":["UK"]},{"name":"Centre of Metabolism, Ageing & Physiology, NIHR, Nottingham BRC, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026060313325292500_ref1","volume-title":"National Diabetes Audit 2022\u201323 Quarterly Report January to September 2022","author":"NHS Digital","year":"2023"},{"key":"2026060313325292500_ref2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/gerona\/62.7.731","article-title":"Frailty: an emerging research and clinical paradigm--issues and controversies","volume":"62","author":"Bergman","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026060313325292500_ref3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2666-7568(20)30014-3","article-title":"Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis","volume":"1","author":"Hanlon","year":"2020","journal-title":"Lancet Healthy Longev"},{"key":"2026060313325292500_ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12111911","article-title":"Multimorbidity, frailty and diabetes in older people-identifying interrelationships and outcomes","volume":"12","author":"Sinclair","year":"2022","journal-title":"J Pers Med"},{"key":"2026060313325292500_ref5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026060313325292500_ref6","volume-title":"ICD-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision, 2nd Ed","author":"World Health Organisation","year":"2004"},{"key":"2026060313325292500_ref7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"key":"2026060313325292500_ref8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"2026060313325292500_ref9","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1109\/TBME.2010.2083659","article-title":"Quantitative falls risk assessment using the timed up and go test","volume":"57","author":"Greene","year":"2010","journal-title":"IEEE Trans Biomed Eng"},{"key":"2026060313325292500_ref10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"2026060313325292500_ref11","volume-title":"Type 2 Diabetes [2015] (Update 2022)","author":"National Institute for Health and Care Excellence","year":"2022"},{"key":"2026060313325292500_ref12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","article-title":"Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European diabetes working party for older people (EDWPOP), and the international task force of experts in diabetes","volume":"13","author":"Sinclair","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"2026060313325292500_ref13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s13300-021-01035-9","article-title":"Diabetes and frailty: an expert consensus statement on the management of older adults with type 2 diabetes","volume":"12","author":"Strain","year":"2021","journal-title":"Diabetes Ther"},{"key":"2026060313325292500_ref14","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/dc24-S013","article-title":"13. Older adults: standards of Care in Diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","journal-title":"Diabetes Care"},{"key":"2026060313325292500_ref15","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2026060313325292500_ref16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"key":"2026060313325292500_ref17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/17446651.2022.2079495","article-title":"Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age \u226560years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies","volume":"17","author":"Crabtree","year":"2022","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026060313325292500_ref18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/ageing\/afy194","article-title":"Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England","volume":"48","author":"Bottle","year":"2019","journal-title":"Age Ageing"},{"key":"2026060313325292500_ref19","first-page":"26853","volume-title":"Akaike Information Criterion Statistics","author":"Sakamoto","year":"1986"},{"key":"2026060313325292500_ref20","first-page":"A368","article-title":"Association between hba1c with cardiovascular (CV) events and all-cause mortality in elderly patients with insulin-treated type 2 diabetes (T2D)","volume":"65","author":"Anyanwagu","year":"2016","journal-title":"Diabetes"},{"key":"2026060313325292500_ref21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/sim.1621","article-title":"A new measure of prognostic separation in survival data","volume":"23","author":"Royston","year":"2004","journal-title":"Stat Med"},{"key":"2026060313325292500_ref22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"key":"2026060313325292500_ref23","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"2026060313325292500_ref24","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.2337\/dc13-0610","article-title":"HbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study","volume":"36","author":"Lipska","year":"2013","journal-title":"Diabetes Care"},{"key":"2026060313325292500_ref25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"2026060313325292500_ref26","doi-asserted-by":"crossref","first-page":"f4533","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Atsushi","year":"2013","journal-title":"BMJ"},{"key":"2026060313325292500_ref27","doi-asserted-by":"publisher","first-page":"e14502","DOI":"10.1111\/dme.14502","article-title":"SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: a systematic review","volume":"38","author":"Escobar","year":"2021","journal-title":"Diabet Med"},{"key":"2026060313325292500_ref28","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","article-title":"SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits","volume":"65","author":"Marilly","year":"2022","journal-title":"Diabetologia"},{"key":"2026060313325292500_ref29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"2026060313325292500_ref30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026060313325292500_ref31","volume-title":"Research Priorities to Improve Care for Older People with Diabetes","author":"Diabetes UK","year":"2022"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/6\/afag149\/68462298\/afag149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/6\/afag149\/68462298\/afag149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:33:01Z","timestamp":1780507981000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag149\/8700864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag149","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6,1]]},"article-number":"afag149"}}